The short answer
Both are hyaluronic acid, and that is where the similarity ends. A skin booster is a thin,
non-cross-linked gel that spreads through the dermis and changes skin quality: hydration,
elasticity, fine lines. A filler is a cross-linked gel engineered to hold its shape and create
volume where tissue has been lost.
Asking which is better is like asking whether primer or plaster is better. They answer
different complaints, and only one of them carries a rare but serious vascular risk.
What the material difference means
Cross-linking is a chemical process that ties hyaluronic acid chains together. The more
cross-linked the gel, the more it resists being flattened by surrounding tissue, and the longer
it stays where it was placed. That property is exactly what a filler needs and exactly what a
booster avoids.
A booster is designed to diffuse. It is injected in small deposits across an area rather than
in one place, and it works by hydrating the dermis and stimulating the skin’s own repair
activity rather than by occupying space.
What boosters are measured to do
The most useful study on this ran against saline as a control (published in the Journal of
Clinical and Aesthetic Dermatology, PMID 36909864). Ten days after the last session of
non-cross-linked hyaluronic acid, crow’s feet wrinkle depth in the 110 to 1000 micrometre range
fell by 10 per cent while the control side rose by 7 per cent. Skin radiance and hydration rose
35 per cent, firmness 27 per cent. The investigator rated the aesthetic appearance improved or
much improved in 82 per cent of subjects on the treated side, and in none on the saline side.
Pore size responds too. A split-face trial of superficial intradermal hyaluronic acid
injections found reduced mean pore volume through week 32 on both sides, with one formulation
24.2 per cent ahead of the other at p of 0.038, and improved hydration on both
(doi 10.1111/jocd.70209). A prospective study of a booster protocol across face, neck and
décolleté reported significant improvement in uniformity, viscoelasticity, firmness, water
content, wrinkle depth and smoothness, sustained through follow-up (doi 10.1111/jocd.70547).
Notice what is absent from all of that: volume, projection, contour. Boosters were not
measured on those because they are not built for them.
Where the risk profiles diverge
Both are injections, so both carry bruising, swelling, tenderness and the possibility of
infection at an injection point. The difference is vascular.
A cross-linked gel placed into or against a vessel can block it. A retrospective series of
290,307 hyaluronic acid injections recorded 2 infections and 10 vascular obstructions, putting
severe complications at 0.0041 per cent (doi 10.1097/SAP.0000000000004327). Eight of those ten
embolisations involved the forehead. Rare, but the consequences at the top of that range include
skin necrosis and vision loss, which is why the treating doctor’s anatomy knowledge matters more
than the brand on the syringe.
Hyaluronidase, the enzyme that dissolves hyaluronic acid, is the reason these products are
preferred over permanent ones: a problem can be reversed. Reviews of its use note good results
and an acceptable safety profile, with dosing that differs by complication type
(doi 10.2196/50403). Having the enzyme available is a readiness measure, not a guarantee, and
speed of recognition decides the outcome.
Boosters, being thin and placed superficially in small deposits, carry a much lower vascular
risk, though it is not zero, and the under-eye area remains the highest-risk zone for any
injectable.
How the choice is actually made
The question at a consultation is what the complaint is, not which product is trendier. Skin
that looks dull, dehydrated and finely lined but has kept its shape is a booster conversation.
Flattened cheekbones, a folded nasolabial line or a chin that has lost projection is a filler
conversation. Many faces have both, and then the order matters more than the choice: structure
first, quality afterwards, with the doctor setting the interval.
One honest limitation applies to boosters: the results in every study above came from courses
of injections, and they faded when treatment stopped. This is maintenance, not correction.
When neither treatment is done
Not performed during pregnancy and breastfeeding, over active skin infection, inflammation or
herpes at the injection site, with a known allergy to hyaluronic acid or injection components,
with bleeding disorders or on anticoagulant therapy without a doctor’s assessment, with
autoimmune or uncontrolled chronic conditions without the same, or with a tendency to keloid
scarring. This list is not exhaustive, and final suitability is determined by a clinician at an
in-person assessment.
Protocols and pricing are on
the skin booster page and
the filler page.
When to call the clinic
Call MED YU MED on +971 52 184 5011, daily 10:00-22:00, if redness spreads rather than
settles, if the skin blisters or breaks, if pain increases after the first day, or if a fever
follows a session. Outside our opening hours go to the nearest emergency department or call 998
for an ambulance rather than waiting for the clinic to reopen. The clinic does not operate 24
hours.
Questions people ask
Can a skin booster replace a filler?
No. Boosters are measured on hydration, elasticity, fine lines and pore size, not on volume or contour. A gel that diffuses through the dermis cannot hold a shape, which is the whole point of a cross-linked filler.
Which one is safer?
Boosters carry lower vascular risk because the gel is thin and placed superficially in small deposits. For fillers, a series of 290,307 injections recorded severe complications at 0.0041 per cent, with eight of ten vascular events in the forehead. Both are injections and both can bruise, swell or become infected.
How long do results last?
Every booster study above measured courses rather than single sessions, and the effect fades once treatment stops. Fillers last longer because the gel resists being broken down, with duration depending on the product and the area.
Can both be done in the same session?
That is a decision for the treating doctor. Where a face needs both, the usual sequence is structure first and skin quality afterwards, with an interval the doctor sets rather than combining everything into one appointment.
References
- The Effects of a Non-crossed-linked Hyaluronic Acid Gel on the Aging Signs of the Face versus Normal Saline: A Randomized Study. J Clin Aesthet Dermatol. 2023;16(2):29-36. PMID 36909864
- Superficial Intradermal Injections of Cohesive Polydensified Matrix Hyaluronic Acid Fillers for Enlarged Facial Pores. J Cosmet Dermatol. 2025;24(5):e70209. doi 10.1111/jocd.70209
- Clinical and Biometric Assessment of a Hyaluronic Acid-Based Skin Booster for Face, Neck and Décolleté. J Cosmet Dermatol. 2025;24(11):e70547. doi 10.1111/jocd.70547
- Serious Complications of Hyaluronic Acid Fillers: A Retrospective Study. Ann Plast Surg. 2025;94(6):630-633. doi 10.1097/SAP.0000000000004327
- Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatol. 2024;7:e50403. doi 10.2196/50403
Reviewed by MED YU MED medical team (DHA-licensed physicians).
Commercial disclosure: MED YU MED provides this treatment as a paid service. Where the
evidence is limited, this page says so rather than filling the gap with confidence.
Medical disclaimer: This page is for informational purposes only and does not replace a
medical consultation.
License statement: MED YU MED operates under DHA License 6589480.
Individual results caveat: Results vary by diagnosis, skin type, and individual response.
